Current Aspects of Polycystic Ovary Syndrome II: Treatment of Hyperandrogenism, Insulin Resistance, and Infertility
December 2019
in “
Orvostudományi Értesítö
”
polycystic ovary syndrome hyperandrogenism insulin resistance infertility oral contraceptives antiandrogens cyproterone acetate spironolactone metformin thiazolidinediones acarbose GLP-1 agonists inositols clomiphene citrate gonadotropins IVF ovarian drilling PCOS birth control pills antiandrogen drugs Actos Byetta Clomid in vitro fertilization
TLDR Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.
This document reviewed treatments for polycystic ovary syndrome (PCOS), focusing on hyperandrogenism, insulin resistance, and infertility. It emphasized that current treatments are not causal but aim to manage symptoms and prevent complications. Lifestyle changes, such as a 5-10% weight reduction, were noted to significantly improve outcomes. For hyperandrogenism, oral contraceptives with antiandrogenic properties and antiandrogens like cyproterone acetate and spironolactone were recommended, though combined contraceptives could increase venous thromboembolism risk. Metformin was highlighted as a primary therapy for insulin resistance due to its additional cardiovascular and anti-cancer benefits. Other insulin resistance treatments included thiazolidinediones, acarbose, GLP-1 agonists, and inositols. For infertility, clomiphene citrate, gonadotropins, IVF, and ovarian drilling were discussed, with a focus on preventing ovarian hyperstimulation syndrome and multiple pregnancies.